Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRH and Esophageal Motility in Healthy Volunteers
NCT02736734Phase 4Completed
- Start
- Oct 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of corticotrophin-releasing hormone in gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), esophageal motility disorder (EMD). Started Oct 2014; status: completed.
02
Drugs
corticotrophin-releasing hormone
03
Conditions
gastroesophageal reflux disease (GERD)irritable bowel syndrome (IBS)esophageal motility disorder (EMD)
Beyond the preview
Go deeper on NCT02736734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736734.